Bank of America
WHWK

Bank of America’s Whitehawk Therapeutics WHWK Stock Holding History

Bank of America’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$182K Buy
52,861
+52,450
+12,762% +$164K ﹤0.01% 5390
2025
Q4 		$995 Buy
411
+365
+793% +$838 ﹤0.01% 6461
2025
Q3 		$87 Sell
46
-365
-89% -$671 ﹤0.01% 7893
2025
Q2 		$769 Buy
411
+231
+128% +$402 ﹤0.01% 7582
2025
Q1 		$320 Buy
180
+8
+5% +$21 ﹤0.01% 7599
2024
Q4 		$543 Sell
172
-41
-19% -$93 ﹤0.01% 7395
2024
Q3 		$438 Sell
213
-2,779
-93% -$4.49K ﹤0.01% 7407
2024
Q2 		$4.37K Sell
2,992
-7,342
-71% -$13.6K ﹤0.01% 7039
2024
Q1 		$24.2K Sell
10,334
-21,215
-67% -$40.9K ﹤0.01% 6715
2023
Q4 		$63.7K Buy
31,549
+11,455
+57% +$48.1K ﹤0.01% 6535
2023
Q3 		$97.3K Buy
20,094
+7,425
+59% +$43.2K ﹤0.01% 6261
2023
Q2 		$86.7K Sell
12,669
-1,183
-9% -$9.2K ﹤0.01% 6259
2023
Q1 		$100K Sell
13,852
-8,210
-37% -$87.7K ﹤0.01% 6256
2022
Q4 		$283K Sell
22,062
-5,545
-20% -$72.4K ﹤0.01% 5732
2022
Q3 		$390K Sell
27,607
-6,165
-18% -$81K ﹤0.01% 5578
2022
Q2 		$416K Sell
33,772
-26,350
-44% -$391K ﹤0.01% 5566
2022
Q1 		$1.02M Buy
60,122
+24,219
+67% +$464K ﹤0.01% 5212
2021
Q4 		$867K Buy
+35,903
New +$902K ﹤0.01% 5419
2021
Q3 		– Sell
-16
Closed – – 8455
2021
Q2 		$0 Sell
16
-117
-88% -$2.67K ﹤0.01% 8156
2021
Q1 		$3K Buy
+133
New +$3.06K ﹤0.01% 7205
2020
Q3 		– Sell
-677
Closed -$13K – 7230
2020
Q2 		$13K Sell
677
-676
-50% -$8.84K ﹤0.01% 6371
2020
Q1 		$12K Buy
1,353
+676
+100% +$6.23K ﹤0.01% 6314
2019
Q4 		$6K Hold
677
– – ﹤0.01% 6745
2019
Q3 		$7K Hold
677
– – ﹤0.01% 6796
2019
Q2 		$9K Hold
677
– – ﹤0.01% 6752
2019
Q1 		$9K Buy
+677
New +$29.1K ﹤0.01% 6690

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Bank of America's WHWK Position: Q1 2026 in Review

Bank of America increased its Whitehawk Therapeutics (WHWK) stake by 12,762% in Q1 2026, buying an estimated $164K and bringing the position to 52,861 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #5390.

Bank of America first reported a position in WHWK in Q1 2019 and has held it in 26 quarters since. The position peaked at $1.02M in Q1 2022. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Bank of America held 52,861 shares of Whitehawk Therapeutics worth $182K as of Q1 2026.
  • Bank of America bought 52,450 Whitehawk Therapeutics shares in Q1 2026, an estimated $164K.
  • Whitehawk Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5390 holding.
  • Bank of America first reported a position in Whitehawk Therapeutics in Q1 2019 and has held it in 26 quarters since.
  • Bank of America's Whitehawk Therapeutics position peaked at $1.02M in Q1 2022.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.